High crude violacein production from glucose by Escherichia coli engineered with interactive control of tryptophan pathway and violacein biosynthetic pathway

Microbial Cell Factories

Volumn 14, Issue 1, 2015, Pages

  Fang, Ming Yue ^a   Zhang, Chong ^a   Yang, Song ^b   Cui, Jin Yu ^b   Jiang, Pei Xia ^c   Lou, Kai ^d   Wachi, Masaaki ^e   Xing, Xin Hui ^a  

^a TSINGHUA UNIVERSITY   (China)

^b QINGDAO AGRICULTURAL UNIVERSITY   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

^d INSTITUTE OF MICROBIOLOGY   (China)

^e TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Escherichia coli; Glucose; Pathway optimization; Tryptophan; Violacein

Indexed keywords

AROMATIC AMINO ACID; CARBON 13; CHORISMIC ACID; ERYTHROSE 4 PHOSPHATE; GLUCOSE; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; PHENYLALANINE; PHOSPHATE; PROTEIN PHEA; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG; VIOLACEIN; BACTERIAL PROTEIN; CARBON; INDOLE DERIVATIVE;

ARTICLE; BATCH FERMENTATION; BATCH REACTOR; BIOMASS; BIOSYNTHESIS; CARBON SOURCE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE CLUSTER; GENE OVEREXPRESSION; INDUSTRIAL PRODUCTION; METABOLIC ENGINEERING; NEGATIVE FEEDBACK; NONHUMAN; PRODUCTIVITY; SIGNAL TRANSDUCTION; TRYPTOPHAN METABOLISM; UPREGULATION; CHEMISTRY; CORYNEBACTERIUM; GENE INACTIVATION; GENETICS; METABOLISM; MULTIGENE FAMILY; PLASMID;

ESCHERICHIA COLI;

BACTERIAL PROTEINS; BIOMASS; CARBON ISOTOPES; CORYNEBACTERIUM; ESCHERICHIA COLI; GENE KNOCKOUT TECHNIQUES; GLUCOSE; INDOLES; METABOLIC ENGINEERING; MULTIGENE FAMILY; PLASMIDS; TRYPTOPHAN;

EID: 84924140841     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/s12934-015-0192-x     Document Type: Article

References (41)

1. Ryan KS, Drennan CL. Divergent pathways in the biosynthesis of bisindole natural products. Chem Biol. 2009;16:351-64.
2. Nelson Durán CFMM. Chromobacterium violaceum: a review of pharmacological and industiral perspectives. Crit Rev Microbiol. 2001;27:201-22.
3. Durán N, Justo GZ, Ferreira CV, Melo PS, Cordi L, Martins D. Violacein: properties and biological activities. Biotechnol Appl Biochem. 2007;48:127-33.
4. Rettori D, Durán N. Production, extraction and purificationof violacein: an antibiotic pigment producedby Chromobacterium violaceum. World J Microb Biot. 1998;14:685-8.
5. Durán N, Antonio RV, Haun M, Pilli RA. Biosynthesis of a trypanocide by Chromobacterium violaceum. World J Microb Biot. 1994;10:686-90.
6. Jiang PX, Wang HS, Zhang C, Lou K, Xing XH. Reconstruction of the violacein biosynthetic pathway from Duganella sp B2 in different heterologous hosts. Appl Microbiol Biotechnol. 2010;86:1077-88.
7. Bromberg N, Durán N. Violacein transformation by peroxidases and oxidases: implications on its biological properties. J Mol Catal B-Enzym. 2001;11:463-7.
8. Jiang PX, Wang HS, Xiao S, Fang MY, Zhang RP, He SY, et al. Pathway redesign for deoxyviolacein biosynthesis in Citrobacter freundii and characterization of this pigment. Appl Microbiol Biotechnol. 2012;94:1521-32.
9. Wang H, Jiang P, Lu Y, Ruan Z, Jiang R, Xing X-H, et al. Optimization of culture conditions for violacein production by a new strain of Duganella sp. B2. Biochem Eng J. 2009;44:119-24.
10. Lu Y, Wang L, Xue Y, Zhang C, Xing X-H, Lou K, et al. Production of violet pigment by a newly isolated psychrotrophic bacterium from a glacier in Xinjiang, China. Biochem Eng J. 2009;43:135-41.
11. Patijanasoontorn B, Boonma P, Wilailackana C, Sitthikesorn J, Lumbiganon P, Chetchotisakd P, et al. Hospital acquired Janthinobacterium lividum septicemia in Srinagarind Hospital. J Med Assoc Thai. 1992;75 Suppl 2:6-10.
12. Ti TY, Tan WC, Chong AP, Lee EH. Nonfatal and fatal infections caused by Chromobacterium violaceum. Clin Infect Dis. 1993;17:505-7.
13. Yang C, Jiang P, Xiao S, Zhang C, Lou K, Xing X-H. Fed-batch fermentation of recombinant Citrobacter freundii with expression of a violacein-synthesizing gene cluster for efficient violacein production from glycerol. Biochem Eng J. 2011;57:55-62.
14. Rodrigues AL, Trachtmann N, Becker J, Lohanatha AF, Blotenberg J, Bolten CJ, et al. Systems metabolic engineering of Escherichia coli for production of the antitumor drugs violacein and deoxyviolacein. Metab Eng. 2013;20:29-41.
15. Rodrigues AL, Becker J, de Souza Lima AO, Porto LM, Wittmann C. Systems metabolic engineering of Escherichia coli for gram scale production of the antitumor drug deoxyviolacein from glycerol. Biotechnol Bioeng. 2014;111:2280-9.
16. Pemberton J, Vincent K, Penfold R. Cloning and heterologous expression of the violacein biosynthesis gene cluster from Chromobacterium violaceum. Curr Microbiol. 1991;22:355-8.
17. Balibar CJ, Walsh CT. In vitro biosynthesis of violacein from l-Tryptophan by the enzymes VioA-E from Chromobacterium violaceum†. Biochemistry. 2006;45:15444-57.
18. Sanchez C, Brana AF, Mendez C, Salas JA. Reevaluation of the violacein biosynthetic pathway and its relationship to indolocarbazole biosynthesis. Chembiochem. 2006;7:1231-40.
19. Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, Leonard E, et al. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science. 2010;330:70-4.
20. Chou HH, Keasling JD. Programming adaptive control to evolve increased metabolite production. Nat Commun. 2013;4:2595.
21. Yoon SH, Lee YM, Kim JE, Lee SH, Lee JH, Kim JY, et al. Enhanced lycopene production in Escherichia coli engineered to synthesize isopentenyl diphosphate and dimethylallyl diphosphate from mevalonate. Biotechnol Bioeng. 2006;94:1025-32.
22. Mendes AS, De Carvalho JE, Duarte MCT, Duran N, Bruns RE. Factorial design and response surface optimization of crude violacein for Chromobacterium violaceum production. Biotechnol Lett. 2001;23:1963-9.
23. Ikeda M. Towards bacterial strains overproducing L-tryptophan and other aromatics by metabolic engineering. Appl Microbiol Biotechnol. 2006;69:615-26.
24. Zhao ZJ, Zou C, Zhu YX, Dai J, Chen S, Wu D, et al. Development of L-tryptophan production strains by defined genetic modification in Escherichia coli. J Ind Microbiol Biotechnol. 2011;38:1921-9.
25. Gu P, Yang F, Kang J, Wang Q, Qi Q. One-step of tryptophan attenuator inactivation and promoter swapping to improve the production of L-tryptophan in Escherichia coli. Microb Cell Fact. 2012;11:30.
26. Yang S, Matsen JB, Konopka M, Green-Saxena A, Clubb J, Sadilek M, et al. Global molecular analyses of methane metabolism in methanotrophic alphaproteobacterium, methylosinus trichosporium OB3b. Part II. Metabolomics and 13C-Labeling study. Front Microbiol. 2013;4:70.
27. Berry A. Improving production of aromatic compounds in Escherichia coli by metabolic engineering. Trends Biotechnol. 1996;14:250-6.
28. Pantanella F, Berlutti F, Passariello C, Sarli S, Morea C, Schippa S. Violacein and biofilm production in Janthinobacterium lividum. J Appl Microbiol. 2007;102:992-9.
29. Rodrigues AL, Gocke Y, Bolten C, Brock NL, Dickschat JS, Wittmann C. Microbial production of the drugs violacein and deoxyviolacein: analytical development and strain comparison. Biotechnol Lett. 2012;34:717-20.
30. Tribe DE, Pittard J. Hyperproduction of tryptophan by Escherichia coli: genetic manipulation of the pathways leading to tryptophan formation. Appl Environ Microbiol. 1979;38:181-90.
31. Aiba S, Tsunekawa H, Imanaka T. New approach to tryptophan production by Escherichia coli: genetic manipulation of composite plasmids in vitro. Appl Environ Microbiol. 1982;43:289-97.
32. Chan E-C, Tsai H-L, Chen S-L, Mou D-G. Amplification of the tryptophan operon gene in Escherichia coli chromosome to increase l-tryptophan biosynthesis. Appl Microbiol Biotechnol. 1993;40:301-5.
33. Stephanopoulos GN, Aristidou AA, Nielsen J. Metabolic engineering-principles and methodologies academic press. 1998.
34. Patnaik R, Liao JC. Engineering of Escherichia coli central metabolism for aromatic metabolite production with near theoretical yield. Appl Environ Microbiol. 1994;60:3903-8.
35. Comba S, Arabolaza A, Gramajo H. Emerging engineering principles for yield improvement in microbial cell design. Comput Struct Biotechnol J. 2012;3:e201210016.
36. Chen Y, Xing X-H, Ye F, Kuang Y, Luo M. Production of MBP-HepA fusion protein in recombinant Escherichia coli by optimization of culture medium. Biochem Eng J. 2007;34:114-21.
37. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006;2:2006.0008.
38. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A. 2000;97:6640-5.
39. Cherepanov PP, Wackernagel W. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene. 1995;158:9-14.
40. Spraggon G, Kim C, Nguyen-Huu X, Yee M-C, Yanofsky C, Mills SE. The structures of anthranilate synthase of Serratia marcescens crystallized in the presence of (i) its substrates, chorismate and glutamine, and a product, glutamate, and (ii) its end-product inhibitor, l-tryptophan. Proc Natl Acad Sci USA. 2001;98:6021-6.
41. Miller GL. Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal Chem. 1959;31:426-8.